Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg
Status:
Completed
Trial end date:
2002-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the bioequivalence of Mylan metformin
hydrochloride ER tablets to Glucophage® XR tablets following a single, oral 500 mg (1 x 500
mg) dose administration under fasting conditions.